DPP4 and type 2 diabetes mellitus: Biological interest in the DPP-4 enzyme has heightened after the discovery and approval of highly selective DPP-4 inhibitors (agents that selectively inactivate DPP-4 and augment the incretin effect) for the treatment of type 2 diabetes [42,43].